TGM2 and acquired idiopathic inflammatory myopathy: Selva-O’Callaghan et al. [4] screened 51 consecutive IIM patients; AGA IgA antibodies were detected in 17 patients (31%), and all patients tested negative for anti-TG2 and EMA antibodies.